The latest news updates from the 2024 Symposium
Carlos H. Barrios, MD, discusses a Tuesday afternoon presentation on single agent endocrine therapy post-CDK 4/6 inhibitors in metastatic HR+ breast cancer.
Jai Min Ryu, MD, PhD, discusses a Tuesday evening poster presentation on the clinicopathologic characteristics and axillary lymph node status of patients enrolled in the NAUTILUS trial.
Bruce Mann, MBBS, PhD, FRACS, discusses a Tuesday evening poster presentation on the impact of treatment de-escalation on fear of cancer recurrence and health-related quality of life.
Fabiana Napolitano, MD; Carmen van Dooijeweert, MD, PhD; and Marcelo Sobral-Leite, PharmD, PhD, discuss their Tuesday evening poster presentations.
Joshua Z. Drago, MD, MS, discusses a Tuesday afternoon presentation on antibody-drug conjugate development across tumor types.
Ashley M. Laughney, PhD, discusses a Tuesday afternoon presentation on the effect of cellular interactions with the tumor microenvironment based on intrinsic single cell variability.
Joanne Kotsopoulos, MSc, PhD, discusses her Tuesday, December 5, presentation on cancer risk associated with exogenous hormone use in BRCA mutation carriers.
Barbara Segarra-Vazquez, DHSc, discusses her Tuesday, December 5, presentation on screening for health-related social needs.